Side Effects: Salt, Steroids, and Second Brains - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Side Effects: Salt, Steroids, and Second Brains

So get this: sodium may track with memory decline (in men), steroids might not be “immunosuppressive” in the ICU, and second pregnancies reshape the brain differently than first. Same theme: biology is less binary than we teach it.

  • By

  • Kerri Miller

  • April 22, 2026

  • 7 min

Share

Clinical Scorecard: Side Effects: Salt, Steroids, and Second Brains

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationOlder men, cognitively unimpaired; predominantly white Australian cohort.
Care Setting

Key Highlights

  • Higher sodium intake linked to faster episodic memory decline in older men, but findings are observational.
  • No significant cognitive decline observed in women related to sodium intake.
  • Sodium reduction may be a modifiable factor for delaying Alzheimer's onset, but further research is needed.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • Potential for overgeneralization of findings beyond the studied cohort; caution advised.

        Patient & Prescribing Data

        Sodium intake averages 1,814 mg/day in men; consider dietary adjustments, noting limitations of dietary assessment methods.

        Clinical Best Practices

        • Incorporate sodium reduction discussions into broader dietary counseling on cardiovascular risk.

        Related Resources & Content

        Original Source(s)

        Side Effects: Salt, Steroids, and Second Brains

        • by Kerri Miller

        • April 22, 2026

        Related Content

        Social vulnerability may contribute to disparities in ovarian cancer survival

        Neighborhood vulnerability was associated with poorer survival among women with epithelial ovarian cancer, with a stronger association among Black women.

        FDA approves serial liquid biopsy testing

        In SERENA-6, patients who changed treatment following detection of an ESR1 mutation had a 56% lower risk of disease progression or death.

        Emergency diagnosis may flag poor outcomes beyond cancer

        Across 13 noncancer conditions, emergency diagnosis was common and associated with higher 1-year mortality.